Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Podcast/Feature Tease

MassDevice Podcast: Nano Surfaces CEO Joe Gatto

By

Coming generations of implanted medical devices will interact with the human body at the molecular level, using sophisticated nano-coatings to not only thwart microbial growth but to perform biological operations.

That’s the prediction of Nano Surfaces founder, president and CEO Joe Gatto. The Boston-based firm is developing technology it’s licensed from Cornell University to create self-assembling, anti-microbial coatings on a nanotech scale — and Gatto says that’s just the beginning. To prove it, he’s hitting to road to raise a Series A round from institutional investors.

MassDevice Podcast: Semprus BioSciences CEO David Lucchino

By

Medical device developers have long sought to reduce the risks involved with implants by applying coatings to prevent both bacteria and blood from sticking to the objects once they’re inside the body.

But coatings can wear off or otherwise lose their effectiveness. Semprus BioSciences Inc. is developing a solution to this fundamental limitation of implanted medical devices with its Sustain technology, which CEO David Lucchino describes as a “physical extension” of the device’s material.

MassDevice Podcast: Edwards Lifesciences CEO Michael Mussallem

By

You could forgive Michael Mussallem if he didn’t want to bid farewell to 2010.

While the rest of us were still trying to pull our heads out of the lingering effects of the so-called “Great Recession,” the 57-year-old chief executive of Edwards LifeSciences Corp. (NYSE:EW) was busy watching his company clean up on Wall Street and set itself up for a sweet run this year.

MassDevice Podcast: Avedro Inc. CEO David Muller

By

More than 20 years ago, David Muller led a revolution in the world of vision correction.

As chairman and CEO of Summit Technology, he led a team that brought the first excimer laser through the Food & Drug Administration for use in reshaping the cornea. The technology, later dubbed Lasik, is a worldwide phenomenon and has helped tens of millions of patients shed glasses and contact lenses.

Decades later, Muller is at it again as the chief executive of Waltham, Mass.-based Avedro Inc., looking to finish what he started, this time with a new vision correction procedure he says will make Lasik safer and more effective.

MassDevice Podcast: Retina Implant CEO Walter Wrobel

By

Restoring vision to the blind is the sort of feat reserved for ancient religious texts and modern science fiction novels. But a company in Germany did just that with an eye implant.

Retina Implant AG is in the process of developing a sub-Retina Implant, designed to be inserted into the eye to treat back-of-the-eye disorders. A first clinical trial showed that the device can enable people suffering from a certain type of macular degeneration to see. The patients had retinitus pigmentosa, an inherited and incurable degenerative condition that causes tunnel vision and often, eventually, complete blindness. Retina Implant estimates that the condition affects about 200,000 people in the U.S. and Europe.

MassDevice Podcast: GE Healthcare’s Earl Jones

By

The term “liberated information” may sound like it was taken from a science fiction novel, but to General Electric’s (NYSE:GE) Earl Jones, it’s a means to improve access and quality to healthcare while at the same time making it cheaper. Jones is the vice president and general manager of the eHealth division of GE Healthcare, overseeing the development of information technology platforms that customers ranging from small doctors’ offices to state governments are implementing into their everyday operations.

MassDevice Podcast: Medtronic CEO William Hawkins

By

For William Hawkins, Medtronic Inc. (NYSE:MDT) runs in the family.

Inside his corner office at the Fridley, Minn.-based medical device goliath, Hawkins, chairman and CEO of one of the world’s largest medical device companies, keeps a picture of two customers he says not only shaped how he sees his company but how he sees the world.